232 related articles for article (PubMed ID: 21261432)
1. The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.
Japuntich SJ; Piper ME; Leventhal AM; Bolt DM; Baker TB
J Consult Clin Psychol; 2011 Feb; 79(1):34-42. PubMed ID: 21261432
[TBL] [Abstract][Full Text] [Related]
2. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.
Piper ME; Smith SS; Schlam TR; Fiore MC; Jorenby DE; Fraser D; Baker TB
Arch Gen Psychiatry; 2009 Nov; 66(11):1253-62. PubMed ID: 19884613
[TBL] [Abstract][Full Text] [Related]
3. Smoker characteristics and smoking-cessation milestones.
Japuntich SJ; Leventhal AM; Piper ME; Bolt DM; Roberts LJ; Fiore MC; Baker TB
Am J Prev Med; 2011 Mar; 40(3):286-94. PubMed ID: 21335259
[TBL] [Abstract][Full Text] [Related]
4. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K
Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585
[TBL] [Abstract][Full Text] [Related]
5. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Doggrell SA
Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
[TBL] [Abstract][Full Text] [Related]
6. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
Rose JE; Behm FM
Nicotine Tob Res; 2017 Aug; 19(8):999-1002. PubMed ID: 29054128
[TBL] [Abstract][Full Text] [Related]
7. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
Saxon AJ; Baer JS; Davis TM; Sloan KL; Malte CA; Fitzgibbons K; Kivlahan DR
Nicotine Tob Res; 2003 Aug; 5(4):589-96. PubMed ID: 12959797
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success.
Raupach T; Brown J; Herbec A; Brose L; West R
Addiction; 2014 Jan; 109(1):35-43. PubMed ID: 23919621
[TBL] [Abstract][Full Text] [Related]
9. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
10. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of combination therapy for smoking cessation.
Shah SD; Wilken LA; Winkler SR; Lin SJ
J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Hays JT; Ebbert JO
Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
[TBL] [Abstract][Full Text] [Related]
13. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
14. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
15. Outcomes from an outpatient smoking-cessation clinic.
Roth MT; Andrus MR; Westman EC
Pharmacotherapy; 2005 Feb; 25(2):279-88. PubMed ID: 15767242
[TBL] [Abstract][Full Text] [Related]
16. Paths to tobacco abstinence: A repeated-measures latent class analysis.
McCarthy DE; Ebssa L; Witkiewitz K; Shiffman S
J Consult Clin Psychol; 2015 Aug; 83(4):696-708. PubMed ID: 25867447
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Chen LS; Bloom AJ; Baker TB; Smith SS; Piper ME; Martinez M; Saccone N; Hatsukami D; Goate A; Bierut L
Addiction; 2014 Jan; 109(1):128-137. PubMed ID: 24033696
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for smoking cessation: current advances and research topics.
Raupach T; van Schayck CP
CNS Drugs; 2011 May; 25(5):371-82. PubMed ID: 21476609
[TBL] [Abstract][Full Text] [Related]
19. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
Hurt RD; Krook JE; Croghan IT; Loprinzi CL; Sloan JA; Novotny PJ; Kardinal CG; Knost JA; Tirona MT; Addo F; Morton RF; Michalak JC; Schaefer PL; Porter PA; Stella PJ
J Clin Oncol; 2003 Mar; 21(5):914-20. PubMed ID: 12610193
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the pharmacotherapy of smoking.
Hughes JR; Goldstein MG; Hurt RD; Shiffman S
JAMA; 1999 Jan; 281(1):72-6. PubMed ID: 9892454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
